FTRE

Rating neutralAI MemoPost-earnings T+3

Fortrea

As of 2026-05-08/Post-earnings T+3/Confidence medium

Open ticker Back to Memos

Data freshness

AI Memo

As of 2026-05-08 • Model: RankAlpha Sentiment Codex

Decision Panel

Action, confidence, horizon, and decision blockers at a glance.

Action

neutral

Confidence

medium

Horizon

—

Key catalyst

Recovery in functional service provider demand and backlog conversion • 2026-08-06

Expected move: -3%

Biggest risk

The quality of the recovery is still incomplete. Revenue fell 2.3% year over year, the 10-Q attributed a 3.2% organic decline partly to weaker functional service provider demand, and management still needs to prove that book-to-bill strength converts into durable revenue and cash flow. Net leverage of 4.4x and negative free cash flow keep the balance-sheet burden material.

Invalidation

Break below $10 or thesis failure.

What would change my mind?

Post-earnings evidence improved: Q1 adjusted EPS of $0.16 beat third-party consensus of $0.03 and revenue of $636.5 million beat third-party consensus near $628.5 million, while guidance was reaffirmed. Delayed Street reaction skewed constructive on May 6, with Citigroup raising its target to $20 from $16 and Barclays raising to $16 from $11 while keeping Hold.

Research note

Recommendation

neutral

Confidence

medium

As of

2026-05-08

Base target

$15

p=45%

Bull target

$20

p=25%

Bear target

$10

p=30%

Key bullets

Fast scan of bull, bear, and watch items

BullKey bullets

Q1 earnings reset needs a second proof point on bookings and cost takeout
FY2026 margin expansion and deleveraging execution
Post-earnings evidence improved: Q1 adjusted EPS of $0.16 beat third-party consensus of $0.03 and revenue of $636.5 million beat third-party consensus near $628.5 million, while guidance was reaffirmed.

BearKey bullets

Backlog is not a clean revenue proxy: the 10-Q says many contracts have 30-90 day termination provisions and backlog can be affected by delays, scope changes, and cancellations [#10-Q-2026-05-05].
Leverage and cash generation remain a constraint, with 4.4x net leverage, negative Q1 free cash flow, and more than $1.0 billion of gross debt [#10-Q-2026-05-05] [#IR-2026-05-05].
Q1 organic revenue declined 3.2%, with lower pass-through costs and lower functional service provider demand only partly offset by higher full-service revenue from net new business [#10-Q-2026-05-05].

WatchKey bullets

Recovery in functional service provider demand and backlog conversion

Summary

High-level snapshot

Recommendation

neutral

Model confidence

medium

Timeframe

Asset

Equity

Trigger

Post-earnings T+3

Base case: $15 (p=45%)

Bull/Bear spread: +31% / -35%

Vs latest close: Bull +31% · Base -3% · Bear -35%

Scenario probabilities

Bull Target: $20 (p=25%)Base Target: $15 (p=45%)Bear Target: $10 (p=30%)

Commentary

Primary-source evidence turned better after the May 5, 2026 print, but this still looks like a monitoring setup rather than a clean bullish rerating. The earnings release and IR deck showed an earnings beat, affirmed guidance, and better bookings, while delayed analyst reaction on May 6 included target increases from Citi and Barclays. Secondary price-history sources indicate a sharp positive move on the earnings date, but exact post-print price action was not independently primary-verified here. Counterbalancing that, analyst coverage is thin, consensus targets remain around or slightly below the May 7 anchor price, and the company still has to prove revenue conversion, cash-flow improvement, and deleveraging.

As of 2026-05-08 • Updated bi-weekly / post-earningsSource: Internal modelMethodology

Analyst Summary

Thesis highlights from the latest analysis

Bull Case

Bear Case

Drivers

Scannable catalysts and supporting factors

Q1 earnings reset needs a second proof point on bookings and cost takeout
FY2026 margin expansion and deleveraging execution

Scenarios

Bull Target (Scenario probability)

$20 / p=25% prob

Base Target (Scenario probability)

$15 / p=45% prob

Bear Target (Scenario probability)

$10 / p=30% prob

Price $15 as of 2026-06-18

Nearest Scenario: Base (∆ 3%)

Targets vs latest close: Bull +31% · Base -3% · Bear -35%

Sentiment & Exposure

News Sentiment (30d)

0.10

Social Sentiment (7d)

0.00

Events

Other notable items detected

EVENT2026-08-06
Recovery in functional service provider demand and backlog conversion
The 10-Q said Q1 organic revenue fell 3.2% because of lower pass-through costs and lower demand in the functional service provider business, partly offset by higher full-service revenue from net new business; evidence that FSP demand stabilizes and backlog converts without cancellations would improve confidence in the growth recovery [#10-Q-2026-05-05].
Prob 45.00% • Move 12.00% • Priced-in 35.00%

Short-term Catalysts

Next few weeks

Q1 earnings reset needs a second proof point on bookings and cost takeout
2026-08-06
Fortrea reported Q1 revenue of $636.5 million, adjusted EBITDA of $47.0 million, adjusted EPS of $0.16, a 1.15x quarterly book-to-bill, and affirmed full-year 2026 guidance; the next decision point is whether bookings stay above replacement levels and cost optimization remains on track rather than Q1 being a one-quarter rebound [#8-K-2026-05-05] [#IR-2026-05-05].
Prob 60% • Move 15% • Priced-in 50%

Long-term Catalysts

Months to a year

FY2026 margin expansion and deleveraging execution
2026-12-31
Management said it is on track for $70-80 million of gross and $40-50 million of net 2026 cost optimization, while Q1 net leverage was 4.4x, free cash flow was negative, and gross debt remained above $1.0 billion; sustained margin improvement with better cash generation is the main medium-term rerating path [#10-Q-2026-05-05] [#IR-2026-05-05].
Prob 50% • Move 25% • Priced-in 30%

Risks

Backlog is not a clean revenue proxy: the 10-Q says many contracts have 30-90 day termination provisions and backlog can be affected by delays, scope changes, and cancellations [#10-Q-2026-05-05].
Leverage and cash generation remain a constraint, with 4.4x net leverage, negative Q1 free cash flow, and more than $1.0 billion of gross debt [#10-Q-2026-05-05] [#IR-2026-05-05].
Q1 organic revenue declined 3.2%, with lower pass-through costs and lower functional service provider demand only partly offset by higher full-service revenue from net new business [#10-Q-2026-05-05].
The 10-K flags persistent CRO price competition, reliance on third parties, and the risk that awards do not convert to signed contracts or revenue as expected [#10-K-2026-02-26].

Peers

Symbol	Summary
ICLR	ICON plc is a direct large-scale CRO peer from Fortrea’s own 2025 peer group, useful for benchmarking full-service clinical development execution and margin recovery pace.
MEDP	Medpace is a more focused CRO peer from Fortrea’s disclosed peer group and is relevant for comparing book-to-bill quality, biotech exposure, and operational discipline.
IQV	IQVIA is in Fortrea’s disclosed peer group and provides a scale benchmark for customer overlap and commercial execution, though its broader data and tech mix makes it a tougher comp on margins.

Sources

Internal and external references used in this analysis

Model source: RankAlpha Sentiment Codex
Human targets: serper
Analysis date: 2026-05-08

AI Stock Memo: FTRE - Fortrea - RankAlpha